Cardiac size, autonomic function, and 5-year follow-up of chronic heart failure patients with severe prolongation of ventricular activation
- 1 April 2003
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 9 (2) , 93-99
- https://doi.org/10.1054/jcaf.2003.15
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effects of Carvedilol on Heart Rate Dynamics in Patients with Congestive Heart FailureAnnals of Noninvasive Electrocardiology, 2002
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Higher Sympathetic Nerve Activity During Ventricular (VVI) Than During Dual-Chamber (DDD) PacingJournal of the American College of Cardiology, 1996
- Modulation of Cardiac Autonomic Control in Humans by Angiotensin IIHypertension, 1995
- Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakersAmerican Heart Journal, 1993
- Effect of captopril on cardiac parasympathetic activity in chronic cardiac failure secondary to coronary artery diseaseThe American Journal of Cardiology, 1992
- Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations.Journal of Clinical Investigation, 1990
- Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysisThe American Journal of Cardiology, 1988